These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30743807)

  • 1. New development in intracrinology of breast carcinoma: therapeutic horizons after aromatase inhibitors.
    Sasano H; Miki Y; Fukuda T; Nagasaki S; Nakata T; Suzuki T
    Expert Rev Endocrinol Metab; 2007 May; 2(3):367-374. PubMed ID: 30743807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New development in intracrinology of breast carcinoma.
    Sasano H; Suzuki T; Nakata T; Moriya T
    Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective estrogen enzyme modulators in breast cancer: a review.
    Pasqualini JR
    Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients.
    Chanplakorn N; Chanplakorn P; Suzuki T; Ono K; Chan MS; Miki Y; Saji S; Ueno T; Toi M; Sasano H
    Breast Cancer Res Treat; 2010 Apr; 120(3):639-48. PubMed ID: 20151319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology.
    Sasano H; Miki Y; Nagasaki S; Suzuki T
    Pathol Int; 2009 Nov; 59(11):777-89. PubMed ID: 19883428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ
    Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracrinology of estrogens and androgens in breast carcinoma.
    Sasano H; Suzuki T; Miki Y; Moriya T
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):181-5. PubMed ID: 17933521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Endocrinology to Intracrinology.
    Sasano H; Suzuki T; Harada N
    Endocr Pathol; 1998; 9(1):9-20. PubMed ID: 12114657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracrinology of sex steroids in ductal carcinoma in situ (DCIS) of human breast: comparison to invasive ductal carcinoma (IDC) and non-neoplastic breast.
    Miki Y; Suzuki T; Sasano H
    J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):68-71. PubMed ID: 19444935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers.
    Hanamura T; Niwa T; Gohno T; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
    Breast Cancer Res Treat; 2014 Jan; 143(1):69-80. PubMed ID: 24292869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
    Hilborn E; Stål O; Jansson A
    Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex steroid-producing enzymes in human breast cancer.
    Suzuki T; Miki Y; Nakamura Y; Moriya T; Ito K; Ohuchi N; Sasano H
    Endocr Relat Cancer; 2005 Dec; 12(4):701-20. PubMed ID: 16322318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracrine mechanism of estrogen synthesis in breast cancer.
    Suzuki T; Moriya T; Ishida T; Ohuchi N; Sasano H
    Biomed Pharmacother; 2003 Dec; 57(10):460-2. PubMed ID: 14637389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas.
    Takagi M; Miki Y; Miyashita M; Hata S; Yoda T; Hirakawa H; Sagara Y; Rai Y; Ohi Y; Tamaki K; Ishida T; Suzuki T; Ouchi N; Sasano H
    Breast Cancer Res Treat; 2016 Feb; 156(1):45-55. PubMed ID: 26943913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
    Santen RJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
    Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
    J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway.
    Santner SJ; Feil PD; Santen RJ
    J Clin Endocrinol Metab; 1984 Jul; 59(1):29-33. PubMed ID: 6725522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.